ES2562854T3 - Use of isosorbide monoesters as fungicidal active products - Google Patents

Use of isosorbide monoesters as fungicidal active products Download PDF

Info

Publication number
ES2562854T3
ES2562854T3 ES12741261.7T ES12741261T ES2562854T3 ES 2562854 T3 ES2562854 T3 ES 2562854T3 ES 12741261 T ES12741261 T ES 12741261T ES 2562854 T3 ES2562854 T3 ES 2562854T3
Authority
ES
Spain
Prior art keywords
formula
isosorbide
sorbitan
compounds
use according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES12741261.7T
Other languages
Spanish (es)
Inventor
Maurice Frederic Pilz
Peter Klug
Franz-Xaver Scherl
Joerg Grohmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Clariant International Ltd
Original Assignee
Clariant International Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Clariant International Ltd filed Critical Clariant International Ltd
Application granted granted Critical
Publication of ES2562854T3 publication Critical patent/ES2562854T3/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005Antimicrobial preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/007Preparations for dry skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin

Abstract

Empleo de uno o varios de los compuestos de la fórmula (I)**Fórmula** donde R es un grupo alquilo lineal o ramificado con 5 a 11 átomos de carbono, o un grupo alquenilo lineal o ramificado, mono- o poliinsaturado, con 5 a 11 átomos de carbono, como fungicida.Use of one or more of the compounds of the formula (I) ** Formula ** where R is a linear or branched alkyl group with 5 to 11 carbon atoms, or a linear or branched, mono- or polyunsaturated alkenyl group, with 5 to 11 carbon atoms, as a fungicide.

Description

DESCRIPCIONDESCRIPTION

Empleo de monoesteres de isosorbida como productos activos fungicidasUse of isosorbide monosteres as fungicidal active products

La presente invencion se refiere al empleo de monoesteres de isosorbida como fungicida.The present invention relates to the use of isosorbide monosters as a fungicide.

En la industria se emplean agentes conservantes o biocidas para proteger productos, como por ejemplo 5 composiciones cosmeticas, dermatologicas o farmaceuticas, formulaciones fitosanitarias, agentes de lavado o limpieza, o colorantes o pinturas, contra el ataque microbiano. Para este fin son conocidos numerosos agentes conservantes. A modo de ejemplo, se pueden emplear a tal efecto agentes conservantes de Annex V de la norma para cosmeticos EU o biocidas de la norma para biocidas EU.In the industry, preservatives or biocides are used to protect products, such as, for example, cosmetic, dermatological or pharmaceutical compositions, phytosanitary formulations, washing or cleaning agents, or dyes or paints, against microbial attack. Numerous preservative agents are known for this purpose. By way of example, preservatives of Annex V of the EU cosmetics standard or biocides of the EU biocides standard can be used for this purpose.

No obstante, en el empleo de muchos agentes conservantes es desventajoso que su obtencion es 10 frecuentemente costosa y se basa en materias primas sinteticas. Ademas, su accion conservante requiere mejora con frecuencia, de modo que son necesarias altas concentraciones de empleo para una conservacion suficiente.However, in the use of many preservative agents it is disadvantageous that their obtaining is frequently expensive and is based on synthetic raw materials. In addition, its preservative action often requires improvement, so that high concentrations of employment are necessary for sufficient preservation.

Por lo tanto, existfa la tarea de poner a disposicion productos activos antimicrobianos, que presentan un rendimiento ventajoso como agente conservante, y ademas se distinguen por la ventaja de basarse en materias 15 primas regenerativas.Therefore, there was the task of making available antimicrobial active products, which have an advantageous yield as a preservative agent, and in addition they are distinguished by the advantage of being based on regenerative raw materials.

Sorprendentemente, ahora se descubrio que este problema se soluciona mediante compuestos de la formula (I)Surprisingly, it was now discovered that this problem is solved by compounds of the formula (I)

imagen1image 1

dondewhere

R es un grupo alquilo lineal o ramificado con 5 a 11, preferentemente 7 a 9, y de modo especialmente 20 preferente 7 atomos de carbono, o un grupo alquenilo lineal o ramificado, mono- o poliinsaturado, con 5 a 11, preferentemente 7 a 9, y de modo especialmente preferente 7 atomos de carbono.R is a linear or branched alkyl group with 5 to 11, preferably 7 to 9, and especially preferably 7 carbon atoms, or a linear or branched, mono- or polyunsaturated alkenyl group, with 5 to 11, preferably 7 to 9, and especially preferably 7 carbon atoms.

Por consiguiente, es objeto de la invencion el empleo de uno o varios compuestos de la formula (I)Therefore, the use of one or more compounds of the formula (I) is the subject of the invention.

imagen2image2

dondewhere

25 R es un grupo alquilo lineal o ramificado con 5 a 11, preferentemente 7 a 9, y de modo especialmente preferente 7 atomos de carbono, o un grupo alquenilo lineal o ramificado, mono o poliinsaturado, con 5 a 11, preferentemente 7 a 9, y de modo especialmente preferente 7 atomos de carbono, como fungicida.R is a linear or branched alkyl group with 5 to 11, preferably 7 to 9, and particularly preferably 7 carbon atoms, or a linear or branched, mono or polyunsaturated alkenyl group, with 5 to 11, preferably 7 to 9 , and especially preferably 7 carbon atoms, as a fungicide.

Los compuestos de la formula (I) presentan muy buen rendimiento como agente conservantes y son apropiados para empleo como fungicidas. Ademas se basan en materias primas regenerativas.The compounds of the formula (I) have very good performance as preservatives and are suitable for use as fungicides. They are also based on regenerative raw materials.

30 En comparacion con el empleo de acidos organicos como agentes conservantes, los compuestos de la formula (I) poseen ademas la ventaja de una eficacia sobre un intervalo de valor de pH mas amplio. Mientras que los acidos organicos muestran frecuentemente una buena accion solo en el intervalo de pH de 3,5 a 6, los compuestos de la formula (I) se pueden emplear ventajosamente tambien a valores de pH mas elevados.In comparison with the use of organic acids as preservatives, the compounds of the formula (I) also have the advantage of an efficacy over a wider pH value range. While organic acids frequently show a good action only in the pH range of 3.5 to 6, the compounds of formula (I) can advantageously also be used at higher pH values.

Las composiciones que se basan al menos parcialmente en materias primas regenerativas y se pueden emplear 35 como agentes conservantes, son ya conocidas.Compositions that are at least partially based on regenerative raw materials and can be used as preservatives are already known.

55

1010

15fifteen

20twenty

2525

3030

3535

4040

El documento DE 10 2009 022 444 (Clariant) describe composiciones Ifquidas que contienen monocaprilato de sorbitano y productos activos antimicrobianos, como por ejemplo acidos organicos especiales y sus sales, donadores de formaldehndo especiales, isotiazolinonas especiales, esteres de parabeno especiales y sus sales, y piridonas especiales y sus sales, asf como su empleo para la conservacion de productos cosmeticos, dermatologicos o farmaceuticos.Document DE 10 2009 022 444 (Clariant) describes liquid compositions containing sorbitan monocaprylate and antimicrobial active products, such as special organic acids and their salts, special formaldehyde donors, special isothiazolinones, special paraben esters and their salts, and Special pyridones and their salts, as well as their use for the preservation of cosmetic, dermatological or pharmaceutical products.

En el documento DE 10 2009 022 445 (Clariant) se dan a conocer composiciones lfquidas que contienen monocaprilato de sorbitano y alcohol y su empleo para la conservacion de productos cosmeticos, dermatologicos o farmaceuticos.In DE 10 2009 022 445 (Clariant) liquid compositions containing sorbitan and alcohol monocaprylate and their use for the preservation of cosmetic, dermatological or pharmaceutical products are disclosed.

En el documento JP 8187070 (A) (Lion) se da a conocer una mezcla de monoesteres de acido graso de acidos grasos Ca-Cia, y al menos un poliol seleccionado a partir de sorbitol, 1,5-sorbitano, 1,4-sorbitano e isosorbida, y diesteres de acido graso de estos acidos grasos y polioles en una proporcion ponderal de monoester : diester de 33 : 7 a 9 : 1 como producto activo antimicrobiano contra bacterias para productos alimenticios o bebidas.JP 8187070 (A) (Lion) discloses a mixture of Ca-Cia fatty acid monoster esters, and at least one polyol selected from sorbitol, 1,5-sorbitan, 1,4- sorbitan and isosorbide, and fatty acid diesters of these fatty acids and polyols in a weight ratio of monoster: diester of 33: 7 to 9: 1 as an antimicrobial active product against bacteria for food products or beverages.

Los compuestos de la formula (I) se pueden obtener, por ejemplo, segun metodos de uso comun para el especialista. A modo de ejemplo, los compuestos de la formula (I) se pueden obtener mediante esterificacion de isosorbida segun metodos habituales y conocidos por el especialista, siendo a su vez adquiribles tanto la propia isosorbida, como tambien los componentes acidos empleados para la esterificacion.The compounds of the formula (I) can be obtained, for example, according to methods of common use for the specialist. By way of example, the compounds of the formula (I) can be obtained by esterification of isosorbide according to customary methods known to the specialist, being in turn both the isosorbide itself, as well as the acidic components used for esterification.

El compuesto o los compuestos de la formula (I) se emplean como fungicida. En el ambito de la presente invencion, esto significa que el compuesto o los compuestos de la formula (I) se pueden emplear preferentemente como producto activo antimicrobiano frente a levaduras y hongos. El compuesto o los compuestos de la formula (I) se emplean de modo especialmente preferente como producto activo antimicrobiano frente a hongos.The compound or compounds of the formula (I) are used as a fungicide. In the scope of the present invention, this means that the compound or compounds of the formula (I) can preferably be used as an antimicrobial active product against yeasts and fungi. The compound or compounds of the formula (I) are used especially preferably as an antimicrobial active product against fungi.

El resto R es preferentemente un resto alquilo lineal saturado con 7 a 9 atomos de carbono en el compuesto o los compuestos de la formula (I). De modo especialmente preferente, el resto R en el compuesto o los compuestos de la formula (I) es un resto alquilo lineal saturado con 7 atomos de carbono.The R moiety is preferably a saturated linear alkyl moiety with 7 to 9 carbon atoms in the compound or compounds of the formula (I). Especially preferably, the R moiety in the compound or compounds of the formula (I) is a linear alkyl moiety saturated with 7 carbon atoms.

Segun la invencion, el compuesto o los compuestos de la formula (I) se pueden emplear como fungicida por separado o en composiciones que contienen una o varias substancias diferentes. Estas composiciones se denominan “composiciones A” a continuacion.According to the invention, the compound or compounds of the formula (I) can be used as a fungicide separately or in compositions containing one or several different substances. These compositions are referred to as "compositions A" below.

En una forma preferente de ejecucion de la invencion, las composiciones A contienen uno o varios compuestos de la formula (I), y adicionalmente una o varias substancias diferentes seleccionadas a partir del grupo constituido por sorbitol, esteres de sorbitol (en el caso de esteres de sorbitol se puede tratar de mono-, di-, tri-, tetra-, penta- y/o hexaesteres), sorbitano, esteres de sorbitano (en el caso de esteres de sorbitano se puede tratar de mono-, di-, tri- y/o tetraesteres), isosorbida, diesteres de isosorbida y acidos carboxflicos. En el caso de “sorbitano” se puede tratar, a modo de ejemplo, de 1,4- o 1,5-sorbitano. Tanto los propios acidos carboxflicos, como tambien los acidos carboxflicos que sirven como base para los componentes acidos de los citados esteres, corresponden a la formula RCOOH, donde R posee el significado indicado en la formula (I), y es preferentemente un resto alquilo lineal saturado con 7 atomos de carbono, es decir, el acido carboxflico RCOOH es preferentemente acido capnlico.In a preferred embodiment of the invention, compositions A contain one or more compounds of the formula (I), and additionally one or several different substances selected from the group consisting of sorbitol, sorbitol esters (in the case of esters sorbitol can be treated as mono-, di-, tri-, tetra-, penta- and / or hexaesters), sorbitan, sorbitan esters (in the case of sorbitan esters it can be treated as mono-, di-, tri - and / or tetraesters), isosorbide, isosorbide diesters and carboxylic acids. In the case of "sorbitan" it can be treated, for example, by 1,4- or 1,5-sorbitan. Both the carboxylic acids themselves, as well as the carboxylic acids that serve as the basis for the acidic components of said esters, correspond to the RCOOH formula, where R has the meaning indicated in the formula (I), and is preferably a linear alkyl moiety saturated with 7 carbon atoms, that is, the RCOOH carboxylic acid is preferably caprylic acid.

En una forma especialmente preferente de ejecucion de la invencion, las composiciones A contienen uno o varios compuestos de la formula (I), y adicionalmenteIn a particularly preferred embodiment of the invention, compositions A contain one or more compounds of the formula (I), and additionally

I) isosorbida yI) isosorbide and

II) uno o varios diesteres de isosorbida de la formula (II)II) one or more isosorbide diesters of the formula (II)

imagen3image3

donde R posee el significado indicado en la formula (I), y siendo el diester de isosorbida preferentemente dicaprilato de isosorbida.where R has the meaning indicated in formula (I), and is the isosorbide diester preferably isosorbide dicaprilate.

55

1010

15fifteen

20twenty

2525

3030

3535

4040

45Four. Five

50fifty

Entre estos, las composiciones A citadas igualmente contienen a su vez preferentemente uno o varios compuestos de la formula (I), y adicionalmenteAmong these, the aforementioned compositions A also preferably contain one or more compounds of the formula (I), and additionally

I) 0,05 a 0,7, preferentemente 0,1 a 0,7, y de modo especialmente preferente 0,2 a 0,5 partes en peso de isosorbida, yI) 0.05 to 0.7, preferably 0.1 to 0.7, and especially preferably 0.2 to 0.5 parts by weight of isosorbide, and

II) 0,1 a 1,0, preferentemente 0,2 a 1,0, y de modo especialmente preferente 0,4 a 0,8 partes en peso de uno o varios diesteres de isosorbida de la formula (II), siendo el diester de isosorbida preferentemente dicaprilato de isosorbida,II) 0.1 to 1.0, preferably 0.2 to 1.0, and particularly preferably 0.4 to 0.8 parts by weight of one or more isosorbide diesters of the formula (II), the isosorbide diester preferably isosorbide dicaprilate,

referido respectivamente a 1,0 parte en peso del compuesto o los compuestos de la formula (I), y referido preferentemente a 1,0 parte en peso de monocaprilato de isosorbida.respectively referred to 1.0 part by weight of the compound or compounds of the formula (I), and preferably referred to 1.0 part by weight of isosorbide monocaprylate.

En una forma, a su vez preferente entre estas, de ejecucion de la invencion, las composiciones A citadas igualmente no contienen acido carboxflico RCOOH, o contienen hasta 0,1, preferentemente 0,001 a 0,05, y de modo especialmente preferente 0,002 a 0,01 partes en peso de acido carboxflico RCOOH, poseyendo R el significado indicado anteriormente en la formula (I), y siendo el acido carboxflico preferentemente acido capnlico, referido a 1,0 parte en peso de uno o varios compuestos de la formula (I), y referido preferentemente a 1,0 parte en peso de monocaprilato de isosorbida.In a manner, in turn preferred among these, of execution of the invention, the aforementioned compositions A also do not contain RCOOH carboxylic acid, or contain up to 0.1, preferably 0.001 to 0.05, and especially preferably 0.002 to 0 , 01 parts by weight of carboxylic acid RCOOH, R having the meaning indicated above in the formula (I), and the carboxylic acid being preferably caprylic acid, referred to 1.0 part by weight of one or more compounds of the formula (I ), and preferably referred to 1.0 part by weight of isosorbide monocaprylate.

En otra forma especialmente preferente de ejecucion de la invencion, las composiciones A contienen uno o varios compuestos de la formula (I) y uno o varios esteres de sorbitano constituidos por sorbitano y acidos carboxflicos RaCOOH, preferentemente seleccionados a partir de esteres de sorbitano constituidos por 1,4- y/oIn another especially preferred embodiment of the invention, compositions A contain one or more compounds of the formula (I) and one or more sorbitan esters consisting of sorbitan and RaCOOH carboxylic acids, preferably selected from sorbitan esters constituted by 1,4- and / or

I, 5-sorbitano y acidos carboxflicos RaCOOH, siendo Ra un grupo alquilo lineal o ramificado, saturado, con 5 aI, 5-sorbitan and RaCOOH carboxylic acids, Ra being a linear or branched alkyl group, saturated, with 5 a

II, preferentemente 7 a 9, y de modo especialmente preferente 7 atomos de carbono, o un grupo alquenilo lineal o ramificado, mono- o poliinsaturado, con 5 a 11, preferentemente 7 a 9, y de modo especialmente preferente 7 atomos de carbono, y siendo la proporcion ponderal del compuesto o de los compuestos de la formula (I) respecto al ester de sorbitano o a los esteres de sorbitano citados igualmente de 70 : 30 a 100 : 0, preferentemente de 80 : 20 a 100 : 0, de modo especialmente preferente de 90 : 10 a 100 : 0, y en especial preferentemente de 95 : 5 a 100 : 0. La proporcion ponderal indicada de “100 : 0” significa que las composiciones A, citadas igualmente, no deben contener ningun ester de sorbitano en esta forma especialmente preferente de ejecucion de la invencion.II, preferably 7 to 9, and particularly preferably 7 carbon atoms, or a linear or branched, mono- or polyunsaturated alkenyl group, with 5 to 11, preferably 7 to 9, and particularly preferably 7 carbon atoms, and the weight ratio of the compound or compounds of the formula (I) being relative to the sorbitan ester or sorbitan esters also mentioned from 70: 30 to 100: 0, preferably from 80: 20 to 100: 0, so especially preferred from 90: 10 to 100: 0, and especially preferably from 95: 5 to 100: 0. The indicated weight ratio of "100: 0" means that compositions A, also mentioned, must not contain any sorbitan esters in this especially preferred form of execution of the invention.

Entre las composiciones A citadas igualmente son preferentes aquellas donde el ester o los esteres de sorbitano constituidos por sorbitano y acidos carboxflicos RaCOOH son seleccionados a partir de esteres de sorbitano constituidos por sorbitano y acido capnlico, y son seleccionados preferentemente a partir de esteres de sorbitano constituidos por 1,4- y/o 1,5-sorbitano y acido capnlico, y el ester de sorbitano es monocaprilato de sorbitano de modo especialmente preferente.Among the aforementioned compositions A, those where the sorbitan ester or esters constituted by sorbitan and RaCOOH carboxylic acids are selected are selected from sorbitan esters constituted by sorbitan and caprylic acid, and are preferably selected from sorbitan esters constituted by 1,4- and / or 1,5-sorbitan and caprylic acid, and the sorbitan ester is sorbitan monocaprylate, particularly preferably.

En estas composiciones A, el mdice de OH de la mezcla del compuesto o los compuestos de la formula (I) y el ester de sorbitano o los esteres de sorbitano (contenidos en caso dado), constituidos por sorbitano y acidos carboxflicos RaCOOH, es preferentemente menor o igual a 320, de modo especialmente preferente menor o igual a 285, en especial preferentemente menor o igual a 245, y de modo extraordinariamente preferente menor o igual a 225.In these compositions A, the OH index of the mixture of the compound or compounds of the formula (I) and the sorbitan ester or the sorbitan esters (contained in the given case), constituted by sorbitan and RaCOOH carboxylic acids, is preferably less than or equal to 320, especially preferably less than or equal to 285, especially preferably less than or equal to 245, and extraordinarily preferably less than or equal to 225.

En otra forma especialmente preferente de ejecucion de la invencion, el mdice de OH de la mezcla del compuesto o los compuestos de la formula (I), y el compuesto o los compuestos seleccionados a partir del grupo constituido por sorbitol, esteres de sorbitol, sorbitano, esteres de sorbitano, isosorbida, diesteres de isosorbida y acidos carboxflicos en las composiciones A, es menor o igual a 320, preferentemente menor o igual a 285, de modo especialmente preferente menor o igual a 245, y en especial preferentemente menor o igual a 225.In another especially preferred embodiment of the invention, the OH index of the mixture of the compound or compounds of the formula (I), and the compound or compounds selected from the group consisting of sorbitol, sorbitol esters, sorbitan , esters of sorbitan, isosorbide, isosorbide diesters and carboxylic acids in compositions A, is less than or equal to 320, preferably less than or equal to 285, especially preferably less than or equal to 245, and especially preferably less than or equal to 225.

En otra forma especialmente preferente de ejecucion de la invencion, las composiciones A no contienen compuestos seleccionados a partir de sorbitol y esteres de sorbitol.In another especially preferred embodiment of the invention, compositions A do not contain compounds selected from sorbitol and sorbitol esters.

En otra forma especialmente preferente de ejecucion de la invencion, las composiciones A no contienen compuestos seleccionados a partir de sorbitano y esteres de sorbitano.In another especially preferred embodiment of the invention, compositions A do not contain compounds selected from sorbitan and sorbitan esters.

En tanto las composiciones A contienen uno o varios compuestos seleccionados a partir de sorbitol y esteres de sorbitol (siendo el acido carboxflico que sirve como base del componente acido de estos esteres preferentemente acido capnlico), estos compuestos estan contenidos en las composiciones A conjuntamente, de modo preferente, en una cantidad menor o igual a un 5,0 % en peso, de modo especialmente preferente en una cantidad menor o igual a un 3,0 % en peso, en especial preferentemente en una cantidad menor o igual a un 1,0 % en peso, y de modo extraordinariamente preferente en una cantidad menor o igual a un 0,5 % en peso,While compositions A contain one or more compounds selected from sorbitol and sorbitol esters (the carboxylic acid serving as the base of the acid component of these esters preferably caprylic acid), these compounds are contained in compositions A together, of preferably, in an amount less than or equal to 5.0% by weight, especially preferably in an amount less than or equal to 3.0% by weight, especially preferably in an amount less than or equal to 1, 0% by weight, and extraordinarily preferably in an amount less than or equal to 0.5% by weight,

44

55

1010

15fifteen

20twenty

2525

3030

3535

4040

refiriendose los datos en % en peso respectivamente al peso total de las composiciones A acabadas.referring the data in% by weight respectively to the total weight of the finished compositions A.

En tanto las composiciones A contengan uno o varios compuestos seleccionados a partir de sorbitano y esteres de sorbitano (siendo el acido carbox^lico que sirve como base para el componente acido de estos esteres preferentemente acido capnlico), estos compuestos estan contenidos conjuntamente, de modo preferente, en una cantidad menor o igual a un 20,0 % en peso, de modo especialmente preferente en una cantidad menor o igual a un 10,0 % en peso, en especial preferentemente en una cantidad menor o igual a un 5,0 % en peso, y de modo extraordinariamente preferente en una cantidad menor o igual a un 1,0 % en peso en las composiciones A, refiriendose los datos en % en peso respectivamente al peso total de las composiciones A acabadas.As long as the compositions A contain one or more compounds selected from sorbitan and sorbitan esters (the carboxylic acid serving as the basis for the acid component of these esters preferably caprylic acid), these compounds are contained together, so preferably, in an amount less than or equal to 20.0% by weight, especially preferably in an amount less than or equal to 10.0% by weight, especially preferably in an amount less than or equal to 5.0 % by weight, and extraordinarily preferably in an amount less than or equal to 1.0% by weight in compositions A, the data in% by weight referring respectively to the total weight of the finished compositions A.

En otra forma especialmente preferente de ejecucion de la invencion, las composiciones A contienen el compuesto o los compuestos de la formula (I) en cantidades de al menos un 30 % en peso, preferentemente en cantidades de al menos un 50 % en peso, y de modo especialmente preferentes en cantidades de al menos un 60 % en peso, referido respectivamente al peso total de las composiciones A acabadas.In another especially preferred embodiment of the invention, compositions A contain the compound or compounds of the formula (I) in amounts of at least 30% by weight, preferably in amounts of at least 50% by weight, and especially preferably in amounts of at least 60% by weight, based respectively on the total weight of the finished compositions A.

Se entiende por mdice de hidroxilo u OH de una substancia aquella cantidad de KOH en mg que es equivalente a la cantidad de acido acetico enlazada en la acetilacion de 1 g de substancia.A hydroxyl index or OH of a substance is understood as that amount of KOH in mg that is equivalent to the amount of acetic acid bound in the acetylation of 1 g of substance.

Metodos de determinacion apropiados para el calculo del mdice de OH son, por ejemplo, DGF C-V 17 a (53), Ph. Eur. 2.5.3 Method A y DIN 53240.Appropriate determination methods for calculating the OH index are, for example, DGF C-V 17 to (53), Ph. Eur. 2.5.3 Method A and DIN 53240.

En el ambito de la presente invencion, los indices de OH se determinan en ajuste a DIN 53240-2. En este caso se procede como sigue: se pesa 1 g sobre 0,1 mg exactamente de la muestra homogeneizada a medir. Se anaden 20,00 ml de mezcla de acetilacion (mezcla de acetilacion: en 1 litro de piridina se introducen con agitacion 50 ml de anhfdrido de acido acetico). La muestra se disuelve completamente en la mezcla de acetilacion, en caso dado bajo agitacion y calentamiento. Se anaden 5 ml de disolucion de catalizador (disolucion de catalizador: se disuelven 2 g de 4-dimetilaminopiridina en 100 ml de piridina). Se cierra el recipiente de reaccion y se coloca 10 minutos en el bano de agua precalentado a 55°C, y en este caso se entremezcla. La disolucion de reaccion se mezcla a continuacion con 10 ml de agua completamente desalinizada, el recipiente de reaccion se cierra de nuevo, y se deja reaccionar de nuevo 10 minutos en bano de agua agitada. La muestra se enfna a temperatura ambiente (25°C). A continuacion se anaden 50 ml de 2- propanol y 2 gotas de fenolftalema. Esta disolucion se titra con hidroxido sodico (hidroxido sodico c = 0,5 mol/l) (Va). Bajo las mismas condiciones, pero sin pesada de muestra, se determina el valor eficaz de la mezcla de acetilacion (Vb).In the scope of the present invention, the OH indices are determined in accordance with DIN 53240-2. In this case, proceed as follows: exactly 1 g is weighed on 0.1 mg of the homogenized sample to be measured. Add 20.00 ml of acetylation mixture (mixture of acetylation: 50 ml of acetic acid anhydride are introduced with stirring in 1 liter of pyridine). The sample is completely dissolved in the acetylation mixture, if necessary under stirring and heating. 5 ml of catalyst solution are added (catalyst solution: 2 g of 4-dimethylaminopyridine are dissolved in 100 ml of pyridine). The reaction vessel is closed and placed 10 minutes in the preheated water bath at 55 ° C, and in this case it is mixed. The reaction solution is then mixed with 10 ml of completely desalinated water, the reaction vessel is closed again, and allowed to react again for 10 minutes in a bath of stirred water. The sample is cooled to room temperature (25 ° C). Then 50 ml of 2- propanol and 2 drops of phenolphthalema are added. This solution is titrated with sodium hydroxide (sodium hydroxide c = 0.5 mol / l) (Va). Under the same conditions, but without sample weighing, the effective value of the acetylation mixture (Vb) is determined.

A partir del consumo de la determinacion del valor eficaz y de la titracion de la muestra se calcula el mdice de OH (OHZ) segun la siguiente formula:From the consumption of the determination of the effective value and the titration of the sample, the OH (OHZ) index is calculated according to the following formula:

imagen4image4

OHZ = mdice de hidroxilo en mg de KOH/g de substancia,OHZ = hydroxyl content in mg of KOH / g of substance,

Va = consumo de hidroxido sodico en ml en la titracion de la muestra,Va = consumption of sodium hydroxide in ml in the titration of the sample,

Vb = consumo de hidroxido sodico en ml en la titracion del valor eficaz,Vb = consumption of sodium hydroxide in ml in the titration of the effective value,

c = concentracion de cantidades de substancia de hidroxido sodico en mol/l, t = tttulo de hidroxido sodico,c = concentration of amounts of sodium hydroxide substance in mol / l, t = title of sodium hydroxide,

M = masa molar de KOH = 56,11 g/mol,M = molar mass of KOH = 56.11 g / mol,

E = pesada de muestra en g.E = sample weight in g.

(Va-Vb) es aquella cantidad de hidroxido sodico empleado en ml, que es equivalente a la cantidad de acido acetico enlazado en la acetilacion de la muestra a medir descrita anteriormente.(Va-Vb) is that amount of sodium hydroxide used in ml, which is equivalent to the amount of acetic acid bound in the acetylation of the sample to be measured described above.

El metodo para la determinacion del mdice de OH, descrito igualmente, se designa a continuacion “metodo OHZ-A”.The method for determining the OH index, also described, is referred to below as the "OHZ-A method".

El empleo segun la invencion tiene lugar preferentemente en composiciones cosmeticas, dermatologicas oThe use according to the invention preferably takes place in cosmetic, dermatological or

55

farmaceuticas, en formulaciones fitosanitarias, en agentes de lavado o limpieza o en colorantes o pinturas. Los agentes fitosanitarios contienen preferentemente uno o varios pesticidas.pharmaceuticals, in phytosanitary formulations, in washing or cleaning agents or in dyes or paints. Phytosanitary agents preferably contain one or more pesticides.

Las composiciones cosmeticas, dermatologicas o farmaceuticas, las formulaciones fitosanitarias, los agentes de lavado o limpieza, o los colorantes o las pinturas, contienen el compuesto o los compuestos de la formula (I) 5 preferentemente en cantidades de un 0,01 a un 10,0 % en peso, de modo especialmente preferente en cantidades de un 0,1 a un 5,0 % en peso, y en especial preferentemente en cantidades de un 0,2 a un 3,0 % en peso, referido respectivamente al peso total de las composiciones cosmeticas, dermatologicas o farmaceuticas acabadas, formulaciones fitosanitarias, agentes de lavado o limpieza o colorantes o pinturas.Cosmetic, dermatological or pharmaceutical compositions, phytosanitary formulations, washing or cleaning agents, or dyes or paints, contain the compound or compounds of formula (I) 5 preferably in amounts of 0.01 to 10 , 0% by weight, especially preferably in amounts of 0.1 to 5.0% by weight, and especially preferably in amounts of 0.2 to 3.0% by weight, respectively based on weight total of the finished cosmetic, dermatological or pharmaceutical compositions, phytosanitary formulations, washing or cleaning agents or dyes or paints.

Las composiciones cosmeticas, dermatologicas o farmaceuticas, las formulaciones fitosanitarias, los agentes de 10 lavado o limpieza o los colorantes o las pinturas tienen viscosidades preferentemente en el intervalo de 50 a 200 000 mPa.s, de modo especialmente preferente en el intervalo de 500 a 100 000 mPa.s, en especial preferentemente en el intervalo de 2 000 a 50 000 mPa.s, y de modo extraordinariamente preferente en el intervalo de 5 000 a 30 000 mPa.s (20°C, Brookfield RVT, set de husillos RV a 20 revoluciones por minuto).Cosmetic, dermatological or pharmaceutical compositions, phytosanitary formulations, washing or cleaning agents or dyes or paints have viscosities preferably in the range of 50 to 200,000 mPa.s, especially preferably in the range of 500 to 100 000 mPa.s, especially preferably in the range of 2,000 to 50,000 mPa.s, and particularly preferably in the range of 5,000 to 30,000 mPa.s (20 ° C, Brookfield RVT, spindle set RV at 20 revolutions per minute).

Las composiciones cosmeticas, dermatologicas o farmaceuticas se presentan preferentemente en forma de 15 fluidos, geles, espumas, sprays, lociones o cremas.Cosmetic, dermatological or pharmaceutical compositions are preferably in the form of fluids, gels, foams, sprays, lotions or creams.

En el caso de las composiciones cosmeticas, dermatologicas o farmaceuticas se trata preferentemente de agentes para el tratamiento de pie de atleta o de agentes anticaspa. El empleo segun la invencion tiene lugar como fungicida contra pie de atleta y contra caspa en estos casos.In the case of cosmetic, dermatological or pharmaceutical compositions, these are preferably agents for the treatment of athlete's foot or anti-dandruff agents. The use according to the invention takes place as a fungicide against athlete's foot and against dandruff in these cases.

Las composiciones cosmeticas, dermatologicas o farmaceuticas, las formulaciones fitosanitarias, los agentes de 20 lavado o limpieza o los colorantes o las pinturas estan constituidos preferentemente sobre base acuosa o acuoso-alcoholica, o se presentan como emulsiones o dispersiones. De modo especialmente preferente se presentan como emulsiones, y en especial se presentan como emulsiones de aceite en agua.Cosmetic, dermatological or pharmaceutical compositions, phytosanitary formulations, washing or cleaning agents or dyes or paints are preferably constituted on an aqueous or aqueous-alcoholic basis, or are presented as emulsions or dispersions. Especially preferably they are presented as emulsions, and in particular they are presented as oil-in-water emulsions.

Las composiciones cosmeticas, dermatologicas o farmaceuticas, las formulaciones fitosanitarias, los agentes de lavado o limpieza, o los colorantes o las pinturas, pueden contener como agentes auxiliares y aditivos 25 adicionales todas las substancias empleadas habitualmente para la respectiva aplicacion, a modo de ejemplo aceites, ceras, emulsionantes, co-emulsionantes, dispersantes, agentes tensioactivos, antiespumantes, solubilizadores, electrolitos, hidroxiacidos, estabilizadores, polfmeros, filmogenos, espesantes, agentes gelificantes, agentes superengrasantes, reengrasantes, otros productos activos antimicrobianos, productos activos biogenos, astringentes, substancias activas, substancias desodorantes, agentes antisolares, 30 antioxidantes, oxidantes, agentes humectantes, disolventes, colorantes, pigmentos, agentes de brillo nacarado, substancias perfumantes, agentes de opacidad y/o siliconas.Cosmetic, dermatological or pharmaceutical compositions, phytosanitary formulations, washing or cleaning agents, or dyes or paints, may contain as additional auxiliary agents and additives all the substances commonly used for the respective application, by way of example oils , waxes, emulsifiers, co-emulsifiers, dispersants, surfactants, defoamers, solubilizers, electrolytes, hydroxyacids, stabilizers, polymers, filmogens, thickeners, gelling agents, super-greasing agents, re-greasers, other antimicrobial active products, biogenic active products, astringent substances active agents, deodorants, antisolar agents, antioxidants, oxidizing agents, wetting agents, solvents, dyes, pigments, pearly shine agents, perfumes, opacifying agents and / or silicones.

Las composiciones cosmeticas, dermatologicas o farmaceuticas, las formulaciones fitosanitarias, los agentes de lavado o limpieza, o los colorantes o las pinturas, poseen valores de pH preferentemente de 2 a 11, de modo especialmente preferente de 4,5 a 8,5, y en especial preferentemente de 5,5 a 6,5.Cosmetic, dermatological or pharmaceutical compositions, phytosanitary formulations, washing or cleaning agents, or dyes or paints, have pH values preferably from 2 to 11, especially preferably from 4.5 to 8.5, and especially preferably from 5.5 to 6.5.

35 Los siguientes ejemplos y aplicaciones deben explicar la invencion mas detalladamente, pero sin limitarla a los mismos. En el caso de todos los datos porcentuales se trata de % en peso (% en peso), en tanto no se indique explfcitamente lo contrario.35 The following examples and applications should explain the invention in more detail, but not limited thereto. In the case of all percentage data, it is% by weight (% by weight), as long as the opposite is not explicitly stated.

Ejemplos comparativosComparative examples

A) Obtencion de caprilato de isosorbidaA) Obtaining isosorbide caprylate

40 En un aparato de agitacion con pieza superpuesta de destilacion se disponen 190,0 g (1,3 moles) de isosorbida (“Sorbon” de Ecogreen Oleochemicals) y 187,5 g (1,3 moles) de acido octanoico (acido capnlico) a 80°C junto con 0,38 g de hidroxido sodico (al 18 % en peso, acuoso), como catalizador. Bajo agitacion y paso de nitrogeno (10-12 litros por hora) se calento la mezcla de reaccion en primer lugar a 180°C, comenzando a destilar el agua de reaccion. La carga se calienta entonces 1 hora a 190°C y en 2 horas mas a 210°C. Una vez alcanzados 45 210°C se esterifica hasta que se ha alcanzado un mdice de acido de < 1 mg de KOH/g. Se obtiene 345,7 g de40 In an agitation apparatus with a superimposed distillation piece, 190.0 g (1.3 mol) of isosorbide (“Sorbon” from Ecogreen Oleochemicals) and 187.5 g (1.3 mol) of octanoic acid (caprylic acid) are placed ) at 80 ° C together with 0.38 g of sodium hydroxide (18% by weight, aqueous), as catalyst. Under stirring and passage of nitrogen (10-12 liters per hour) the reaction mixture was heated first to 180 ° C, beginning to distill the reaction water. The charge is then heated 1 hour at 190 ° C and in another 2 hours at 210 ° C. Once 45 210 ° C is reached, it is esterified until an acid value of <1 mg of KOH / g has been reached. 345.7 g of

caprilato de isosorbida de color ambar (97 % de la teona). El valor de pH (5 % en peso en etanol/agua 1 : 1) asciende a 5,9. El valor de pH se midio segun DIN EN 1262.amber colored isosorbide caprylate (97% of the theone). The pH value (5% by weight in ethanol / water 1: 1) amounts to 5.9. The pH value was measured according to DIN EN 1262.

Otros datos caractensticos analtticos de caprilato de isosorbida:Other characteristic characteristics of isosorbide caprilat:

mdice de acido: 0,9 mg de KOH/g, medido segun DIN EN ISO 2114,Acid index: 0.9 mg KOH / g, measured according to DIN EN ISO 2114,

^ndice de hidroxilo: mdice de saponificacion: El caprilato de isosorbida^ Hydroxyl Index: Saponification Index: Isosorbide Caprylate

206 mg de KOH/g, medido en ajuste a DIN 53240-2 segun metodo OHZ-A, 204 mg de KOH/g, medido segun DIN EN ISO 3681. posee la siguiente composicion:206 mg of KOH / g, measured in accordance with DIN 53240-2 according to OHZ-A method, 204 mg of KOH / g, measured according to DIN EN ISO 3681. It has the following composition:

Substancia  Substance
% en peso  % in weigh

Acido capnlico  Caprylic acid
0,4  0.4

Isosorbida  Isosorbide
18,1  18.1

Monocaprilato de isosorbida  Isosorbide Monocaprylate
50,9  50.9

Dicaprilato de isosorbida  Isosorbide Dicaprilate
30,6  30.6

5 Esta composicion se denomina a continuacion “caprilato de isosorbida 1).5 This composition is referred to below as "isosorbide caprylate 1).

B) Determinacion de la eficacia antimicrobiana de caprilato de isosorbida 1B) Determination of the antimicrobial efficacy of isosorbide caprylate 1

A continuacion se investiga la eficacia antimicrobiana de caprilato de isosorbida 1 en butilpoliglicol contra bacterias, hongos y levaduras. Para el ensayo con bacterias se diluyo caprilato de isosorbida 1 con butilpoliglicol y a continuacion se anadio a caso-agar (casema-peptona-agar) hquido, tamponado a pH 7 (+/- 0,2) a 50°C en 10 diferentes concentraciones (a continuacion llamadas composiciones B1, B2, etc.). Para el ensayo con hongos y con levaduras se diluyo caprilato de isosorbida 1 con butilpoliglicol, y a continuacion se anadio a agar Sabouraud-4 %-dextrosa lfquido, tamponado a pH 5,6 (+/- 0,2) en diferentes concentraciones (a continuacion llamadas composiciones PH1, PH2, etc.). Cada una de las composiciones B1, B2, etc, o bien PH1, PH2, etc, se vertio en placas de Petri, y se inoculo respectivamente con la misma cantidad de bacterias, hongos y levaduras. 15 La concentracion de inhibicion minima (MHK) es la concentracion a la que se presenta una inhibicion del crecimiento de bacterias, hongos y levaduras en las composiciones B1, B2, etc, o bien PH1, PH2, etc.The antimicrobial efficacy of isosorbide caprylate 1 in butyl polyglycol against bacteria, fungi and yeasts is investigated below. For the test with bacteria, isosorbide caprylate 1 was diluted with butyl polyglycol and then added to case-agar (casema-peptone-agar), buffered at pH 7 (+/- 0.2) at 50 ° C in 10 different concentrations (then called compositions B1, B2, etc.). For the fungal and yeast assay, isosorbide caprylate 1 was diluted with butyl polyglycol, and then liquid Sabouraud-4% -dextrose agar was added, buffered to pH 5.6 (+/- 0.2) in different concentrations (a continuation called compositions PH1, PH2, etc.). Each of the compositions B1, B2, etc, or PH1, PH2, etc., was poured into Petri dishes, and inoculated respectively with the same amount of bacteria, fungi and yeasts. The minimum inhibition concentration (MHK) is the concentration at which there is an inhibition of the growth of bacteria, fungi and yeasts in the compositions B1, B2, etc., or PH1, PH2, etc.

Los valores determinados e indicados a continuacion en la tabla 1 para las concentraciones de inhibicion mmimas de caprilato de isosorbida 1 ya estan corregidos en el efecto de dilucion de butilpoliglicol.The values determined and indicated in Table 1 below for the minimum inhibition concentrations of isosorbide caprylate 1 are already corrected in the dilution effect of butyl polyglycol.

Tabla 1: concentraciones de inhibicion mmimas (MHK) de caprilato de isosorbida 1Table 1: mmimal inhibition concentrations (MHK) of isosorbide caprylate 1

Bacterias (B), hongos (P) o levaduras (H) investigados  Bacteria (B), fungi (P) or yeast (H) investigated
MHK de caprilato de isosorbida 1 [ppm]  MHK of isosorbide caprylate 1 [ppm]

Staphylococcus aureus (B)  Staphylococcus aureus (B)
2500  2500

Pseudomonas aeruginosa (B)  Pseudomonas aeruginosa (B)
10000  10000

Escherichia coli (B)  Escherichia coli (B)
7500  7500

Enterobacter aerogenes (B)  Enterobacter aerogenes (B)
10000  10000

Klebsiella pneumoniae (B)  Klebsiella pneumoniae (B)
10000  10000

Proteus vulgaris (B)  Proteus vulgaris (B)
5000  5000

Pseudomonas oleovorans (B)  Pseudomonas oleovorans (B)
10000  10000

Citrobacter freundii (B)  Citrobacter freundii (B)
10000  10000

Bacterias (B), hongos (P) o levaduras (H) investigados  Bacteria (B), fungi (P) or yeast (H) investigated
MHK de caprilato de isosorbida 1 [ppm]  MHK of isosorbide caprylate 1 [ppm]

Candida albicans (H)  Candida albicans (H)
600  600

Aspergillus brasiliensis (P)  Aspergillus brasiliensis (P)
800  800

Penicillium minioluteum (P)  Penicillium minioluteum (P)
600  600

Aspergillus terreus (P)  Aspergillus terreus (P)
600  600

Fusarium solani (P)  Fusarium solani (P)
600  600

Penicillium funicolosium (P)  Penicillium funicolosium (P)
400  400

En los resultados indicados en la tabla 1 se identifica que caprilato de isosorbida 1 posee una eficacia antimicrobiana, en especial contra las levaduras Candida albicans y los hongos sometidos a ensayo.The results indicated in Table 1 identify that isosorbide caprylate 1 has an antimicrobial efficacy, especially against Candida albicans yeasts and the fungi tested.

C) Eficacia antimicrobiana de componentes de caprilato de isosorbida 1C) Antimicrobial efficacy of components of isosorbide caprylate 1

5 Acido capnlico posee una eficacia antimicrobiana. No obstante, ya que acido capnlico se presenta en la composicion „caprilato de isosorbida 1“ solo en un 0,4 % en peso, su eficacia antimicrobiana en esta composicion es despreciablemente reducida. Ademas, acido capnlico no tiene una eficacia antimicrobiana a valores de pH de 6 o mas.5 Caprylic acid has an antimicrobial efficacy. However, since caprylic acid is present in the composition „isosorbide caprylate 1“ only by 0.4% by weight, its antimicrobial efficacy in this composition is negligibly reduced. In addition, caprylic acid does not have an antimicrobial efficacy at pH values of 6 or more.

Analogamente a la determinacion de la eficacia antimicrobiana de caprilato de isosorbida 1, en series de ensayos 10 adicionales se determino la eficacia antimicrobiana de una mezcla que contiene un 89,6 % en peso de dicaprilato de isosorbida y un 9,4 % en peso de monocaprilato de isosorbida (resto: 1 % en peso) (a continuacion llamado „dicaprilato de isosorbida") por una parte, e isosorbida pura por otra parte. Los resultados se representan en la tabla 2.Analogously to the determination of the antimicrobial efficacy of isosorbide caprylate 1, in series of additional trials 10 the antimicrobial efficacy of a mixture containing 89.6% by weight of isosorbide dicaprilate and 9.4% by weight of isosorbide monocaprylate (rest: 1% by weight) (then called "isosorbide dicaprilate") on the one hand, and pure isosorbide on the other hand. The results are shown in Table 2.

Tabla 2: concentraciones de inhibicion mmimas (MHK) de dicaprilato de isosorbida e isosorbidaTable 2: mmimal inhibition concentrations (MHK) of isosorbide and isosorbica dicaprilate

Bacterias (B), hongos (P) o levaduras (H) investigados  Bacteria (B), fungi (P) or yeast (H) investigated
MHK de dicaprilato de isosorbida [ppm] MHK de isosorbida [ppm]  MHK of isosorbide dicaprilate [ppm] MHK of isosorbide [ppm]

Staphylococcus aureus (B)  Staphylococcus aureus (B)
10000 10000  10000 10000

Pseudomonas aeruginosa (B)  Pseudomonas aeruginosa (B)
10000 10000  10000 10000

Escherichia coli (B)  Escherichia coli (B)
10000 10000  10000 10000

Enterobacter aerogenes (B)  Enterobacter aerogenes (B)
10000 10000  10000 10000

Klebsiella pneumoniae (B)  Klebsiella pneumoniae (B)
10000 10000  10000 10000

Proteus vulgaris (B)  Proteus vulgaris (B)
10000 10000  10000 10000

Pseudomonas oleovorans (B)  Pseudomonas oleovorans (B)
10000 10000  10000 10000

Bacterias (B), hongos (P) o levaduras (H) investigados  Bacteria (B), fungi (P) or yeast (H) investigated
MHK de dicaprilato de isosorbida [ppm] MHK de isosorbida [ppm]  MHK of isosorbide dicaprilate [ppm] MHK of isosorbide [ppm]

Citrobacter freundii (B)  Citrobacter freundii (B)
10000 10000  10000 10000

Candida albicans (H)  Candida albicans (H)
10000 10000  10000 10000

Aspergillus brasiliensis (P)  Aspergillus brasiliensis (P)
10000 10000  10000 10000

Penicillium minioluteum (P)  Penicillium minioluteum (P)
10000 10000  10000 10000

Aspergillus terreus (P)  Aspergillus terreus (P)
10000 10000  10000 10000

Fusarium solani (P)  Fusarium solani (P)
5000 10000  5000 10000

Penicillium funicolosium (P)  Penicillium funicolosium (P)
5000 10000  5000 10000

Como se desprende de los resultados de la tabla 2, ni isosorbida ni dicaprilato de isosorbida poseen una eficacia antimicrobiana.As can be seen from the results in Table 2, neither isosorbide nor isosorbide dicaprilate has an antimicrobial efficacy.

Debido a la deficiente eficacia antimicrobiana de los compuestos acido capnlico, isosorbida y dicaprilato de 5 isosorbida contenidos en la composicion caprilato de isosorbida 1 por una parte, y a la eficacia antimicrobiana de la composicion „caprilato de isosorbida 1“ que se desprende de los resultados de la tabla 1 por otra parte, se concluye que el compuesto monocaprilato de isosorbida, contenido igualmente en la composicion caprilato de isosorbida 1, posee una eficacia antimicrobiana significativa, en especial como fungicida frente a levaduras y hongos.Due to the poor antimicrobial efficacy of the compounds of capnolic acid, isosorbide and dicaprilate of 5 isosorbide contained in the isosorbide caprylate composition 1 on the one hand, and to the antimicrobial efficacy of the composition "isosorbide caprylate 1" that follows from the results of Table 1, on the other hand, concludes that the isosorbide monocaprylate compound, also contained in the isosorbide caprylic composition 1, has significant antimicrobial efficacy, especially as a fungicide against yeasts and fungi.

Por este motivo se parte de que la actividad insignificante de la composicion dicaprilato de isosorbida frente a los 10 hongos Fusarium solani y Penicillium funicolosium se puede atribuir al compuesto monocaprilato de isosorbida contenido en la misma.For this reason, it is based on the fact that the insignificant activity of the isosorbide dicaprilate composition against the 10 Fusarium solani and Penicillium funicolosium fungi can be attributed to the isosorbide monocaprylate compound contained therein.

D) Ejemplos de aplicacionD) Application examples

El empleo segun la invencion puede tener lugar, a modo de ejemplo, en las siguientes formulaciones.The use according to the invention can take place, by way of example, in the following formulations.

Ejemplo de formulacion 1: crema hidratante revitalizanteFormulation example 1: revitalizing moisturizer

Fase  Phase
Substancia de contenido % en peso  Substance of content% by weight

Hostacerin® SFO 2,0  Hostacerin® SFO 2.0

Sunflower Seed Oil Sorbitol Esters  Sunflower Seed Oil Sorbitol Esters

Velsan® CCT 4,5  Velsan® CCT 4,5

Trigliceridos capnlicos/capricos  Caprylic / capric triglycerides

Cetiol® OE 4,5  Cetiol® OE 4,5

A  TO
Dicaprilileter  Dicaprilileter

Fase  Phase
Substancia de contenido % en peso  Substance of content% by weight

Lanette® 22 4,0  Lanette® 22 4.0

Alcohol behenico  Behenic alcohol

Lanette® 18 4,0  Lanette® 18 4.0

Alcohol estearico  Steary alcohol

Fucogel® 1000 1,0  Fucogel® 1000 1.0

Goma biosacarida-1  Biosacarid gum-1

B  B
Coenzyme® Q 10 0,1  Coenzyme® Q 10 0.1

Ubiquinonas  Ubiquinonas

C  C
Agua hasta 100  Water up to 100

Glicerina 10,0  Glycerin 10.0

Hostaphat® CK 100 0,6  Hostaphat® CK 100 0.6

Cetilfosfato potasico  Potassium Cetylphosphate

D  D
Fenoxietanol 1,0  Phenoxyethanol 1.0

Caprilato de isosorbida 1 1,0  Isosorbide Caprilate 1 1.0

E  AND
NaOH (al 10 % en peso en agua) qs.  NaOH (10% by weight in water) qs.

Obtencion:Obtaining:

I se mezclan los componentes de A y se calienta a 80°C,I mix the components of A and heat to 80 ° C,

II se mezclan los componentes de C y se calienta a 80°C,II the components of C are mixed and heated to 80 ° C,

5 III se anade B a I,5 III adds B to I,

IV se anade II a III y se agita hasta que la mezcla se ha enfriado a temperature ambiente,IV is added II to III and stirred until the mixture has cooled to room temperature,

V se anade D a IV,V is added D to IV,

VI se ajusta el valor de pH con E a 5,5.VI the pH value is adjusted with E to 5.5.

Ejemplo de formulacion 2:Formulation example 2:

Fase  Phase
Substancia de contenido % en peso  Substance of content% by weight

Hostacerin® EWO poligliceril-2-sesquiisoestearatos (y) cera Alba (y) cera Carnauba (y) estearato de etilhexilo (y) estearato de magnesio (y) estearato de magnesio (y) estearato de aluminio 16,0  Hostacerin® EWO polyglyceryl-2-sesquiisoestearates (y) Alba wax (y) Carnauba wax (y) ethylhexyl stearate (y) magnesium stearate (y) magnesium stearate (y) aluminum stearate 16.0

A  TO
Palmitato de isopropilo 10,0  Isopropyl Palmitate 10.0

Aceite de aguacate  Avocado oil
2,0  2.0

Velsan® CCT 2,5  Velsan® CCT 2.5

Trigliceridos capnlicos/capricos  Caprylic / capric triglycerides

Octopirox® 0,05  Octopirox® 0.05

B  B
Piroctone Olamine  Piroctone Olamine

Propilenglicol 1,0  Propylene Glycol 1.0

C  C
Agua hasta 100  Water up to 100

Glicerina 4,0  Glycerin 4.0

Sulfato de magnesio * 7 H2O 0,7  Magnesium sulfate * 7 H2O 0.7

Alantoma 0,5  0.5 Alantoma

Acetato de tocoferilo 0,5  0.5 tocopheryl acetate

Rosmarinus Officinalis (Rosemary) Leaf Oil 0,1  Rosmarinus Officinalis (Rosemary) Leaf Oil 0.1

D  D
Urea 10,0  Urea 10.0

Caprilato de isosorbida 1 1,0  Isosorbide Caprilate 1 1.0

Fenoxietanol 0,8  Phenoxyethanol 0.8

Obtencion:Obtaining:

I se mezclan los componentes de A y se calienta a 80°C,I mix the components of A and heat to 80 ° C,

II se mezclan los componentes de B hasta que todas las substancias estan disueltas (eventualmente bajoII the components of B are mixed until all substances are dissolved (eventually low

5 ligero calentamiento),5 slight heating),

III se anade II a I,III is added II to I,

IV se mezclan los componentes de C y se calienta a 50°C,IV the components of C are mixed and heated to 50 ° C,

V se agita IV con alta velocidad hasta enfriamiento a 35°C,V is stirred IV with high speed until cooling to 35 ° C,

VI se anade D a 35°C a V.VI is added D at 35 ° C to V.

Ejemplos de formulacion 3 y 4: formulaciones fitosanitariasFormulation examples 3 and 4: phytosanitary formulations

N° de formulacion  Form No.
3 4  3. 4

Substancia de contenido  Content Substance
Cantidad de substancia de contenido respectiva [% en peso]  Amount of substance of respective content [% by weight]

Atrazina  Atrazine
43,6 43,6  43.6 43.6

Dispersogen® PSL 100  Dispersogen® PSL 100
- 1,7  - 1.7

Genapol® LSS  Genapol® LSS
- 1,6  - 1.6

Dispersogen® LFS  Dispersogen® LFS
2,1 -  2.1 -

Propilenglicol  Propylene glycol
4,3 4,3  4.3 4.3

Defoamer® SE 57  Defoamer® SE 57
0,6 0,6  0.6 0.6

Kelzan® S (2 % en peso en agua)  Kelzan® S (2% by weight in water)
7,3 7,3  7.3 7.3

Caprilato de isosorbida 1  Isosorbide Caprilate 1
0,3 0,2  0.3 0.2

Alcohol bendlico  Blessed alcohol
1,0 1,0  1.0 1.0

Agua  Water
hasta 100 hasta 100  up to 100 up to 100

5 Obtencion:5 Obtaining:

El producto activo se dispersa previamente con las demas substancias de contenido (excepto la disolucion de Kelzan®S), y a continuacion se somete a un molturado fino, hasta que el tamano de partfcula medio asciende a < 2 micrometos. A continuacion se introduce con agitacion la disolucion de Kelzan®S.The active product is previously dispersed with the other substances of content (except the solution of Kelzan®S), and then it is subjected to a fine grinding, until the average particle size amounts to <2 micrometres. The solution of Kelzan®S is then introduced with stirring.

Ejemplo de formulacion 5: detergente lavavajillas manualFormulation example 5: manual dishwashing detergent

Substancia de contenido  Content Substance
% en peso  % in weigh

Hostapur® SAS 60 (alcanosulfonato, 60 % en peso en agua)  Hostapur® SAS 60 (alkanesulfonate, 60% by weight in water)
40,0  40.0

Hostapur® OS liquid (C14-16 alquilsulfonato sodico, 40 % en peso en agua)  Hostapur® OS liquid (C14-16 sodium alkylsulfonate, 40% by weight in water)
11,0  11.0

Genaminox® LA (oxido de dimetil-lauramina, 30 % en peso en agua)  Genaminox® LA (dimethyl lauramine oxide, 30% by weight in water)
3,0  3.0

Genagen® CAB (coco-amidopropilbetama, 30 % en peso en agua)  Genagen® CAB (coco-amidopropyl betaine, 30% by weight in water)
3,0  3.0

Substancia de contenido  Content Substance
% en peso  % in weigh

Caprilato de isosorbida 1  Isosorbide Caprilate 1
0,8  0.8

Alcohol bendlico  Blessed alcohol
0,8  0.8

Agua  Water
hasta 100  up to 100

Ejemplo de formulacion 6: limpiador de superficies (limpiador universal)Formulation example 6: surface cleaner (universal cleaner)

Substancia de contenido  Content Substance
% en peso  % in weigh

Hostapur® SAS 60 (alcanosulfonato, 60 % en peso en agua)  Hostapur® SAS 60 (alkanesulfonate, 60% by weight in water)
5,0  5.0

Genapol® UD 080 (undecanol + 8 EO)  Genapol® UD 080 (undecanol + 8 EO)
2,0  2.0

Genaminox® LA (oxido de dimetil-lauramina, 30 % en peso en agua)  Genaminox® LA (dimethyl lauramine oxide, 30% by weight in water)
2,0  2.0

Metilisotiazolinona  Methylisothiazolinone
0,01  0.01

Caprilato de isosorbida 1  Isosorbide Caprilate 1
1,0  1.0

Agua  Water
hasta 100  up to 100

Obtencion de los ejemplos de formulacion 5 y 6Obtaining formulation examples 5 and 6

5 Se dispone la mitad de la cantidad de agua, y se introduce con agitacion los componentes en el orden que se indica en las tablas indicadas en los ejemplos de formulacion 5 y 6. Despues se anade adicionalmente la cantidad de agua restante. Resultan composiciones claras, acuosas.5 Half of the amount of water is disposed, and the components are introduced with agitation in the order indicated in the tables indicated in the examples of formulations 5 and 6. Then the remaining amount of water is added further. Clear, aqueous compositions result.

Claims (14)

55 1010 15fifteen 20twenty 2525 3030 REIVINDICACIONES 1.- Empleo de uno o varios de los compuestos de la formula (I)1.- Use of one or more of the compounds of the formula (I) imagen1image 1 dondewhere R es un grupo alquilo lineal o ramificado con 5 a 11 atomos de carbono, o un grupo alquenilo lineal o ramificado, mono- o poliinsaturado, con 5 a 11 atomos de carbono,R is a linear or branched alkyl group with 5 to 11 carbon atoms, or a linear or branched, mono- or polyunsaturated alkenyl group, with 5 to 11 carbon atoms, como fungicida.as a fungicide 2. - Empleo segun la reivindicacion 1, caracterizado por que el resto R en la formula (I) es un resto alquilo lineal saturado con 7 a 9 atomos de carbono.2. - Use according to claim 1, characterized in that the R moiety in the formula (I) is a saturated linear alkyl moiety with 7 to 9 carbon atoms. 3. - Empleo segun la reivindicacion 2, caracterizado por que el resto R en la formula (I) es un resto alquilo lineal saturado con 7 atomos de carbono.3. - Use according to claim 2, characterized in that the R moiety in formula (I) is a linear alkyl moiety saturated with 7 carbon atoms. 4. - Empleo segun una o varias de las reivindicaciones 1 a 3, caracterizado por que se emplean el compuesto o los compuestos de la formula (I) en una composicion que contiene uno o varias substancias diferentes seleccionadas a partir del grupo constituido por sorbitol, esteres de sorbitol, sorbitano, esteres de sorbitano, isosorbida, diesteres de isosorbida y acidos carboxflicos.4. - Use according to one or more of claims 1 to 3, characterized in that the compound or compounds of the formula (I) are used in a composition containing one or several different substances selected from the group consisting of sorbitol, esters of sorbitol, sorbitan, esters of sorbitan, isosorbide, diesters of isosorbide and carboxylic acids. 5. - Empleo segun la reivindicacion 4, caracterizado por que la composicion contiene uno o varios compuestos de la formula (I), y adicionalmente5. - Use according to claim 4, characterized in that the composition contains one or more compounds of the formula (I), and additionally I) isosorbida yI) isosorbide and II) uno o varios diesteres de isosorbida de la formula (II)II) one or more isosorbide diesters of the formula (II) imagen2image2 donde R posee el significado indicado en la formula (I).where R has the meaning indicated in formula (I). 6. - Empleo segun la reivindicacion 4 o 5, caracterizado por que la composicion contiene uno o varios compuestos de la formula (I), y adicionalmente6. - Use according to claim 4 or 5, characterized in that the composition contains one or more compounds of the formula (I), and additionally I) 0,05 a 0,7 partes en peso de isosorbida, yI) 0.05 to 0.7 parts by weight of isosorbide, and II) 0,1 a 1,0 partes en peso de uno o varios diesteres de isosorbida de la formula (II), referido respectivamente a 1,0 parte en peso del compuesto o los compuestos de la formula (I).II) 0.1 to 1.0 parts by weight of one or more isosorbide diesters of the formula (II), respectively referred to 1.0 part by weight of the compound or compounds of the formula (I). 7. - Empleo segun una o varias de las reivindicaciones 4 a 6, caracterizado por que la composicion contiene uno o varios compuestos de la formula (I) y uno o varios esteres de sorbitano constituidos por sorbitano y acidos carboxflicos RaCOOH, siendo Ra un grupo alquilo lineal o ramificado, saturado, con 5 a 11 atomos de carbono, o un grupo alquenilo lineal o ramificado, mono- o poliinsaturado, con 5 a 11 atomos de carbono, y la proporcion7. - Use according to one or several of claims 4 to 6, characterized in that the composition contains one or more compounds of the formula (I) and one or more sorbitan esters consisting of sorbitan and RaCOOH carboxylic acids, Ra being a group linear or branched alkyl, saturated, with 5 to 11 carbon atoms, or a linear or branched, mono- or polyunsaturated alkenyl group, with 5 to 11 carbon atoms, and the proportion 1414 55 1010 15fifteen 20twenty 2525 ponderal del compuesto o de los compuestos de la formula (I) respecto al ester de sorbitano o a los esteres de sorbitano citados igualmente es de 70 : 30 a 100 : 0.The weight of the compound or compounds of the formula (I) with respect to the sorbitan ester or the sorbitan esters also mentioned is from 70: 30 to 100: 0. 8. - Empleo segun la reivindicacion 7, caracterizado porque el ester de sorbitano o los esteres de sorbitano constituidos por sorbitano y acidos carboxflicos RaCOOH son seleccionados a partir de esteres de sorbitano constituidos por sorbitano y acido capnlico.8. - Use according to claim 7, characterized in that the sorbitan ester or sorbitan esters consisting of sorbitan and RaCOOH carboxylic acids are selected from sorbitan esters constituted by sorbitan and caprylic acid. 9. - Empleo segun una o varias de las reivindicaciones 4 a 8, caracterizado porque el mdice de OH de la mezcla de uno o varios compuestos de la formula (I) y de uno o varios compuestos seleccionados a partir del grupo constituido por sorbitol, esteres de sorbitol, sorbitano, esteres de sorbitano, isosorbida, diesteres de isosorbida y acidos carboxflicos en la composicion es menor o igual a 320.9. - Use according to one or more of claims 4 to 8, characterized in that the OH index of the mixture of one or more compounds of the formula (I) and one or more compounds selected from the group consisting of sorbitol, esters of sorbitol, sorbitan, esters of sorbitan, isosorbide, diesters of isosorbide and carboxylic acids in the composition is less than or equal to 320. 10. - Empleo segun una o varias de las reivindicaciones 4 a 9, caracterizado porque la composicion contiene el compuesto o los compuestos de la formula (I) en cantidades de al menos un 30 % en peso, referido respectivamente al peso total de la composicion acabada.10. - Use according to one or more of claims 4 to 9, characterized in that the composition contains the compound or compounds of the formula (I) in amounts of at least 30% by weight, respectively based on the total weight of the composition finished 11. - Empleo segun una o varias de las reivindicaciones 1 a 10 en composiciones cosmeticas, dermatologicas o farmaceuticas, en formulaciones fitosanitarias, en agentes de lavado o limpieza, o en colorantes o pinturas.11. - Use according to one or more of claims 1 to 10 in cosmetic, dermatological or pharmaceutical compositions, in phytosanitary formulations, in washing or cleaning agents, or in dyes or paints. 12. - Empleo segun la reivindicacion 11, caracterizado porque las composiciones cosmeticas, dermatologicas o farmaceuticas, las formulaciones fitosanitarias, los agentes de lavado o limpieza, o los colorantes o las pinturas, contienen uno o varios compuestos de la formula (I) en cantidades de un 0,01 a un 10,0 % en peso, referido respectivamente al peso total de las composiciones cosmeticas, dermatologicas o farmaceuticas acabadas, formulaciones fitosanitarias, agentes de lavado o limpieza, o colorantes o pinturas.12. - Use according to claim 11, characterized in that the cosmetic, dermatological or pharmaceutical compositions, phytosanitary formulations, washing or cleaning agents, or dyes or paints, contain one or more compounds of the formula (I) in amounts from 0.01 to 10.0% by weight, referring respectively to the total weight of the finished cosmetic, dermatological or pharmaceutical compositions, phytosanitary formulations, washing or cleaning agents, or colorants or paints. 13. - Empleo segun la reivindicacion 11 o 12, caracterizado porque las composiciones cosmeticas, dermatologicas o farmaceuticas, las formulaciones fitosanitarias, los agentes de lavado o limpieza, o los colorantes o las pinturas, estan constituidas sobre base acuosa o acuoso-alcoholica, o se presentan como emulsion o dispersion, y preferentemente como emulsion.13. - Use according to claim 11 or 12, characterized in that the cosmetic, dermatological or pharmaceutical compositions, phytosanitary formulations, washing or cleaning agents, or dyes or paints, are constituted on an aqueous or aqueous-alcoholic basis, or they are presented as an emulsion or dispersion, and preferably as an emulsion. 14. - Empleo segun una o varias de las reivindicaciones 11 a 13, caracterizado porque las composiciones cosmeticas, dermatologicas o farmaceuticas, las formulaciones fitosanitarias, los agentes de lavado o limpieza, o los colorantes o las pinturas, presentan un valor de pH de 2 a 11.14. - Use according to one or more of claims 11 to 13, characterized in that the cosmetic, dermatological or pharmaceutical compositions, phytosanitary formulations, washing or cleaning agents, or dyes or paints, have a pH value of 2 to 11.
ES12741261.7T 2011-08-04 2012-07-31 Use of isosorbide monoesters as fungicidal active products Active ES2562854T3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102011109435 2011-08-04
DE102011109435 2011-08-04
PCT/EP2012/003246 WO2013017257A1 (en) 2011-08-04 2012-07-31 Use of isosorbide monoesters as antimicrobial active substances

Publications (1)

Publication Number Publication Date
ES2562854T3 true ES2562854T3 (en) 2016-03-08

Family

ID=46601751

Family Applications (1)

Application Number Title Priority Date Filing Date
ES12741261.7T Active ES2562854T3 (en) 2011-08-04 2012-07-31 Use of isosorbide monoesters as fungicidal active products

Country Status (7)

Country Link
US (1) US9730450B2 (en)
EP (1) EP2739146B1 (en)
JP (1) JP6027112B2 (en)
CN (1) CN103747679B (en)
BR (1) BR112014002670A2 (en)
ES (1) ES2562854T3 (en)
WO (1) WO2013017257A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102009022445A1 (en) 2009-05-23 2009-12-24 Clariant International Limited Liquid composition, useful e.g. to preserve cosmetic, dermatological or pharmaceutical products, preferably e.g. creams, cream gel, lotions, shampoos, shower baths, wet wipes and deodorants, comprises sorbitan monocaprylate and alcohol
CN103717065B (en) 2011-08-04 2017-01-18 克拉里安特国际有限公司 Use of isosorbide diesters as thickeners
BR112014002612B1 (en) 2011-08-04 2020-02-27 Clariant International Ltd. Compositions comprising isosorbide monoesters and hydroxypyridones and their uses
JP6579750B2 (en) 2011-08-04 2019-09-25 クラリアント・インターナシヨナル・リミテツド Composition comprising isosorbide monoester and isosorbide diester
ES2639115T3 (en) 2011-08-04 2017-10-25 Clariant International Ltd. Use of isosorbide monoesters as a thickener
JP6120845B2 (en) 2011-08-04 2017-04-26 クラリアント・インターナシヨナル・リミテツド Composition comprising isosorbide monoester and an alcohol containing at least one aromatic group
US9862908B2 (en) * 2012-01-17 2018-01-09 Croda, Inc. Seal swell additive
EP2990024B1 (en) 2014-08-26 2019-09-25 Oleon N.V. Pigment concentrate
US10597402B2 (en) 2015-03-27 2020-03-24 Sytheon Limited Compositions and methods for restoring epidermal integrity and function and treating dermatological diseases
DK3273951T3 (en) 2015-03-27 2020-11-02 Symbionyx Pharmaceuticals Inc Compositions and methods for treating psoriasis
WO2016156505A1 (en) * 2015-04-01 2016-10-06 Basf Se Isosorbide ether derivatives with preservation activity
EP3285732B1 (en) * 2015-04-24 2019-11-20 Basf Se Isosorbide diesters as pearlescent agent and clouding agent
EP3406300B1 (en) 2015-04-30 2020-10-14 Clariant International Ltd Use of an estolide ester containing cosmetic composition as a silicone replacement
KR101959994B1 (en) 2017-07-25 2019-03-21 순천대학교 산학협력단 Antimicrobial isosorbide derivatives and antimicrobial composition comprising the same
FR3074423B1 (en) * 2017-12-01 2020-03-06 Roquette Freres USE OF DINAHYDROHEXITOL IN ORAL HYGIENE TO REDUCE THE DEVELOPMENT OF BACTERIAL STRAINS
FR3094217A1 (en) 2019-03-28 2020-10-02 Roquette Freres Use of dianhydrohexitol for the preservation of cosmetic preparations
WO2023247803A2 (en) * 2022-12-20 2023-12-28 Clariant International Ltd Antimicrobial combinations

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3331742A (en) 1963-07-02 1967-07-18 Drew Chem Corp Sterile mono- and di-glyceride pharmaceutical vehicle product for water and/or oil-soluble therapeutic substances
US3394009A (en) * 1964-07-24 1968-07-23 Atlas Chem Ind Preparation of baked products
DE2234009C3 (en) 1972-07-11 1979-01-11 Hoechst Ag, 6000 Frankfurt Cosmetic preparations
JPS557017A (en) * 1978-06-28 1980-01-18 Kao Corp Preparation of ground fish meat
DE3328372A1 (en) 1982-08-06 1984-03-01 Sutton Laboratories, Inc., 07928 Chatham, N.J. COMPOSITION CONTAINING IMIDAZOLIDINYL UREA AND PARABENS
JPS59175408A (en) 1983-03-23 1984-10-04 Nippon Saafuakutanto Kogyo Kk Cosmetic
US4637930A (en) 1984-02-08 1987-01-20 Yamanouchi Pharmaceutical Co, Ltd. Transdermal formulation of nicardipine hydrochloride
US4847088A (en) 1988-04-28 1989-07-11 Dow Corning Corporation Synergistic antimicrobial composition
JP2743101B2 (en) 1989-11-27 1998-04-22 チッソ株式会社 Ethanol preparation for food preservation
JPH08173787A (en) 1994-08-12 1996-07-09 Lion Corp Surface-active agent composition
JPH08187070A (en) 1994-11-10 1996-07-23 Lion Corp Antimicrobial agent for food/beverage and food/beverage
JPH09291016A (en) 1996-04-25 1997-11-11 Sunstar Inc Hair cosmetic material
US6413529B1 (en) 1999-04-13 2002-07-02 The Procter & Gamble Company Antimicrobial wipes which provide improved residual benefit versus gram negative bacteria
DE10206759A1 (en) 2002-02-19 2003-08-28 Dragoco Gerberding Co Ag Use of 1,2-alkanediol mixture as an antimicrobial agent, e.g. for treating body odor, acne or mycoses or preserving perishable products
JP2003238396A (en) 2002-02-21 2003-08-27 Nisshin Pharma Inc Coenzyme q10-containing emulsified composition
WO2006081969A1 (en) 2005-02-03 2006-08-10 Clariant Produkte (Deutschland) Gmbh Preservatives
FR2883877B1 (en) 2005-04-01 2008-10-10 Roquette Freres PROCESS FOR THE PREPARATION OF DIANHYDROHEXITOL DIESTER (S) COMPOSITIONS
DE102006004353A1 (en) 2006-01-30 2007-08-02 Goldschmidt Gmbh Cold-preparable, low-viscosity and long-term stable cosmetic emulsions
US9555167B2 (en) 2006-12-11 2017-01-31 3M Innovative Properties Company Biocompatible antimicrobial compositions
DE102007028702A1 (en) 2007-06-21 2008-12-24 Evonik Oxeno Gmbh Process for the preparation of dianhydrohexitol diesters
US20100113664A1 (en) 2008-06-11 2010-05-06 Ferro Corporation Asymmetric Cyclic Diester Compounds
EP1972330B1 (en) 2008-06-13 2012-09-12 Clariant Finance (BVI) Limited Cosmetic or pharmaceutical compositions comprising modified polysiloxanes with at least one carbamate group
DE102009001748A1 (en) 2009-03-23 2010-09-30 Evonik Goldschmidt Gmbh Formulations containing sorbitan carboxylic acid ester
EP2239315A1 (en) 2009-04-09 2010-10-13 Cognis IP Management GmbH Isosorbide monoesters and their use in household applications
DE102009022445A1 (en) 2009-05-23 2009-12-24 Clariant International Limited Liquid composition, useful e.g. to preserve cosmetic, dermatological or pharmaceutical products, preferably e.g. creams, cream gel, lotions, shampoos, shower baths, wet wipes and deodorants, comprises sorbitan monocaprylate and alcohol
DE102009022444A1 (en) * 2009-05-23 2010-01-07 Clariant International Limited Liquid composition, useful to preserve e.g. cream, comprises sorbitan monocaprylate and antimicrobial agent comprising organic acid and its salts, formaldehyde donor, isothiazolinone, paraben ester and its salts and pyridone and its salts
US8496917B2 (en) 2009-11-13 2013-07-30 Sytheon Ltd Compositions and methods for improving skin appearance
JP2014521664A (en) 2011-08-04 2014-08-28 クラリアント・インターナシヨナル・リミテツド Composition containing isosorbide monoester and isothiazolinones
CN103717072A (en) 2011-08-04 2014-04-09 克拉里安特国际有限公司 Compositions comprising isosorbide monoesters and halogenated antimicrobial active substances
CN103717065B (en) * 2011-08-04 2017-01-18 克拉里安特国际有限公司 Use of isosorbide diesters as thickeners
JP6120845B2 (en) 2011-08-04 2017-04-26 クラリアント・インターナシヨナル・リミテツド Composition comprising isosorbide monoester and an alcohol containing at least one aromatic group
JP6173315B2 (en) 2011-08-04 2017-08-02 クラリアント・インターナシヨナル・リミテツド Cosmetic, dermatological or pharmaceutical composition containing isosorbide diester and UV filter
JP6579750B2 (en) * 2011-08-04 2019-09-25 クラリアント・インターナシヨナル・リミテツド Composition comprising isosorbide monoester and isosorbide diester
US20160000080A1 (en) 2011-08-04 2016-01-07 Clariant International Ltd. Compositions containing isosorbide monoester and aliphatic vicinal diols
BR112014002612B1 (en) * 2011-08-04 2020-02-27 Clariant International Ltd. Compositions comprising isosorbide monoesters and hydroxypyridones and their uses
DE102011119033A1 (en) 2011-11-22 2012-09-06 Clariant International Ltd. Use of a composition comprising isosorbide caprylate/caprate in antiperspirant and deodorant to improve their effect for reducing the body odor

Also Published As

Publication number Publication date
CN103747679A (en) 2014-04-23
JP2014525916A (en) 2014-10-02
EP2739146A1 (en) 2014-06-11
WO2013017257A1 (en) 2013-02-07
EP2739146B1 (en) 2015-11-25
JP6027112B2 (en) 2016-11-16
CN103747679B (en) 2017-07-11
US9730450B2 (en) 2017-08-15
BR112014002670A2 (en) 2017-03-01
US20140315996A1 (en) 2014-10-23

Similar Documents

Publication Publication Date Title
ES2562854T3 (en) Use of isosorbide monoesters as fungicidal active products
ES2610236T3 (en) Composition containing isosorbide monoesters and isosorbide diesters
JP6081551B2 (en) Composition comprising sorbitan monocaprylate and antibacterial active substance
ES2440647T3 (en) Composition containing sorbitan and alcohol monocaprylate
US9358199B2 (en) Use of isosorbide diesters as thickeners
US9555117B2 (en) Use of isosorbide monoesters as thickeners
JP5008573B2 (en) Preservative
BR112016022235B1 (en) ANTIMICROBIAL DERMAL CONCENTRATE
JP5872838B2 (en) Antibacterial composition
US8367079B2 (en) Liquid preservative compositions
US9993000B2 (en) Isosorbide ether derivatives with preservation activity
AU2011361982B2 (en) Antibacterial or preserving composition containing 3-butoxy-1,2-propanediol
KR101788179B1 (en) Low irritation skin external application composition with an improved antiseptic ability
KR102158895B1 (en) Preservative system
JP2016540787A (en) Composition comprising ferulic acid ethyl ester and arylalkanol